Common characteristics of IE-IRFs
| Gene . | IRF1 . | IRF3 . | IRF4 . | IRF6 . | IRF7 . | IRF8 . | IRF9 . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inheritance pattern . | AR . | AD (HSE) . | AD . | AD (T95R) . | AD (F359L) . | AD (R98W) . | AR (V405Gfs Ter127) . | AD (VWS) . | AD (PPS) . | AR . | AD . | AR . | AD . | AR . | |
| Mechanism . | LOF . | HI . | HI . | MM . | MM . | HI . | UPD . | HI . | DN . | LOF . | ? . | LOF . | DN . | LOF . | |
| Bacterial susceptibility | ✔ | | | ✔ | ✔ | ✔ | ? | | | | | ✔ | ✔ | | |
| Viral susceptibility | | ✔ | ✔ | ✔ | ✔ | | ✔ | | | ✔ | ✔ | ✔ | ✔ | ✔ | |
| Known pathogen range | Weakly virulent mycobacteria + Histoplasma capsulatum | HSV | Respiratory viral infections: Severe SARS-CoV-2 and influenza | P. jirovecii, vaccine strain BCG, M. bovis, CMV, EBV, … (see Table 2) | CMV, HSV, VZV, oral mycosis, G. lamblia, onychomycosis, … (see Table 2) | Tw | Rotavirus, C. albicans, HSV, respiratory infections (unknown cause) | No known infection susceptibility | No known infection susceptibility | Respiratory viral infections: severe SARS-CoV-2 and influenza + RSV, TBE virus, and adenovirus | Respiratory viral infections: severe SARS-CoV-2 and influenza | Weakly virulent mycobacteria | Respiratory viral infections: severe SARS-CoV-2 and influenza + eight other viruses (see Table 2) | ||
| + EBV, influenza, C. albicans, rhinovirus, HPV, CMV, and mycoplasma | + EBV, HPV, recurrent Clostridium difficile | ||||||||||||||
| Cellular abnormalities | CD4+ T cells | ↑↓ | | | ↓ | ↑↓ | | ↑↓ | | | | | ↓ | ↑ | ↓ |
| CD8+ T cells | ↑↓ | | | | ↑↓ | | ↓ | | | | | ↓ | | | |
| NK cells | ↓↓ | | | | | | | | | | | ↓ | | ↓ | |
| B cells | ↑ | | | ↓↓ | ↓ | | ↓ | | | | | ↓ | ↓ | ↓ | |
| DCs | ↓ | | | | | | ↑↓ | | | | | ↓↓/↓↓↓ | ↓ | | |
| Monocytes | | | | | | | ↑↓ | | | | | ↓↓/↓↓↓ | ↑ | | |
| IFN impairment | IFN-γ | IFN-α/β | IFN-α/β | IFN-γ | | IFN-γ | IFN-γ | | | IFN-α/β/λ1 | IFN-α/β | IFN-γ | IFN-α | IFN-α | |
| Gene expression defect | ↓ | ↓ | ↓ | ↑↓ | ↑↓ | ↓ | ↓ | Likely ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ||
| Other defects | Reduced innate lymphoid precursors | | | Hypogammaglobulinemia | Hypogammaglobulinemia, premature hair graying | | Agammaglobulinemia, hypereosinophilia, and hemophagocytosis | Lip pits and CLP | Lip pits, CLP, popliteal webbing, syndactyly, hypodontia, and deformities of the limbs and genitals | Impaired viral control in fibroblasts and pulmonary epithelia | Impaired IAV control in macrophages | Increased hypofunctional granulocytes. Intracerebral calcification and developmental delay | Mild neutrophilia | Impaired IAV control in fibroblasts, hypogammaglobulinemia | |
| Gene . | IRF1 . | IRF3 . | IRF4 . | IRF6 . | IRF7 . | IRF8 . | IRF9 . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inheritance pattern . | AR . | AD (HSE) . | AD . | AD (T95R) . | AD (F359L) . | AD (R98W) . | AR (V405Gfs Ter127) . | AD (VWS) . | AD (PPS) . | AR . | AD . | AR . | AD . | AR . | |
| Mechanism . | LOF . | HI . | HI . | MM . | MM . | HI . | UPD . | HI . | DN . | LOF . | ? . | LOF . | DN . | LOF . | |
| Bacterial susceptibility | ✔ | | | ✔ | ✔ | ✔ | ? | | | | | ✔ | ✔ | | |
| Viral susceptibility | | ✔ | ✔ | ✔ | ✔ | | ✔ | | | ✔ | ✔ | ✔ | ✔ | ✔ | |
| Known pathogen range | Weakly virulent mycobacteria + Histoplasma capsulatum | HSV | Respiratory viral infections: Severe SARS-CoV-2 and influenza | P. jirovecii, vaccine strain BCG, M. bovis, CMV, EBV, … (see Table 2) | CMV, HSV, VZV, oral mycosis, G. lamblia, onychomycosis, … (see Table 2) | Tw | Rotavirus, C. albicans, HSV, respiratory infections (unknown cause) | No known infection susceptibility | No known infection susceptibility | Respiratory viral infections: severe SARS-CoV-2 and influenza + RSV, TBE virus, and adenovirus | Respiratory viral infections: severe SARS-CoV-2 and influenza | Weakly virulent mycobacteria | Respiratory viral infections: severe SARS-CoV-2 and influenza + eight other viruses (see Table 2) | ||
| + EBV, influenza, C. albicans, rhinovirus, HPV, CMV, and mycoplasma | + EBV, HPV, recurrent Clostridium difficile | ||||||||||||||
| Cellular abnormalities | CD4+ T cells | ↑↓ | | | ↓ | ↑↓ | | ↑↓ | | | | | ↓ | ↑ | ↓ |
| CD8+ T cells | ↑↓ | | | | ↑↓ | | ↓ | | | | | ↓ | | | |
| NK cells | ↓↓ | | | | | | | | | | | ↓ | | ↓ | |
| B cells | ↑ | | | ↓↓ | ↓ | | ↓ | | | | | ↓ | ↓ | ↓ | |
| DCs | ↓ | | | | | | ↑↓ | | | | | ↓↓/↓↓↓ | ↓ | | |
| Monocytes | | | | | | | ↑↓ | | | | | ↓↓/↓↓↓ | ↑ | | |
| IFN impairment | IFN-γ | IFN-α/β | IFN-α/β | IFN-γ | | IFN-γ | IFN-γ | | | IFN-α/β/λ1 | IFN-α/β | IFN-γ | IFN-α | IFN-α | |
| Gene expression defect | ↓ | ↓ | ↓ | ↑↓ | ↑↓ | ↓ | ↓ | Likely ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ||
| Other defects | Reduced innate lymphoid precursors | | | Hypogammaglobulinemia | Hypogammaglobulinemia, premature hair graying | | Agammaglobulinemia, hypereosinophilia, and hemophagocytosis | Lip pits and CLP | Lip pits, CLP, popliteal webbing, syndactyly, hypodontia, and deformities of the limbs and genitals | Impaired viral control in fibroblasts and pulmonary epithelia | Impaired IAV control in macrophages | Increased hypofunctional granulocytes. Intracerebral calcification and developmental delay | Mild neutrophilia | Impaired IAV control in fibroblasts, hypogammaglobulinemia | |
HI, haploinsufficiency; DN, dominant negative; MM, multimorphic; HSE, herpes simplex encephalitis; LOF, loss of function; TBE, tick-borne encephalitis; cellular abnormalities, abnormal count/function; IFN impairment, abnormal production/response; ↑, elevated; ↓, reduced; ↑↓, mixed effect or variable by genotype. See Table 2 for a detailed characterization of each IE-IRF.